Biofrontera (BFRI) Operating Expenses (2020 - 2025)

Biofrontera's Operating Expenses history runs 6 years deep, the most recent figure standing at $12.5 million for Q4 2025.

• In Q4 2025, Operating Expenses fell 12.12% year-over-year to $12.5 million; the TTM figure through Dec 2025 stood at $53.1 million (down 2.72% YoY), while the FY2025 annual figure was $53.1 million, down 2.71% from the prior year.
• Operating Expenses was $12.5 million for Q4 2025 at Biofrontera, down from $13.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $20.4 million in Q3 2021 to a low of $8.0 million in Q3 2022.
• Historically, Operating Expenses has averaged $13.0 million across 5 years, with a median of $13.3 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Operating Expenses soared 265.24% in 2021, then sank 61.05% in 2022.
• A 5-year view of Operating Expenses shows it stood at $11.0 million in 2021, then soared by 42.69% to $15.8 million in 2022, then decreased by 8.27% to $14.5 million in 2023, then decreased by 1.31% to $14.3 million in 2024, then dropped by 12.12% to $12.5 million in 2025.
• The last three Operating Expenses figures came in at $12.5 million (Q4 2025), $13.3 million (Q3 2025), and $14.1 million (Q2 2025), per Business Quant data.